ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
iShares Core Moderate Allocation ETF

iShares Core Moderate Allocation ETF (AOM)

44.05
-0.08
(-0.18%)
終了 11月21日 6:00AM
44.05
0.00
( 0.00% )
プレマーケット: 6:00PM

個人投資家向けのプロ仕様のツール。

主要統計と詳細

通貨
44.05
買値
-
売値
-
出来高
-
0.00 日の範囲 0.00
39.9201 52 週間の範囲 45.31
時価総額
前日終値
44.05
始値
-
時刻
最終取引時間
-
財務取引量
-
VWAP
-
平均取引量 (3 か月)
92,567
発行済株式数
31,800,000
配当利回り
-
PER
10.31
1 株当たり利益 (EPS)
4.27
歳入
42.4M
純利益
135.92M

iShares Core Moderate Allocation ETF について

The investment seeks to track the investment results of the S&P Target Risk Moderate Index composed of a portfolio of underlying equity and fixed income funds intended to represent a moderate target risk allocation strategy. The fund is a fund of funds and seeks its investment objective by investing... The investment seeks to track the investment results of the S&P Target Risk Moderate Index composed of a portfolio of underlying equity and fixed income funds intended to represent a moderate target risk allocation strategy. The fund is a fund of funds and seeks its investment objective by investing primarily in underlying funds that themselves seek investment results corresponding to their own respective underlying indexes. It generally will invest at least 90% of its assets in the component securities of the underlying index. The index measures the performance of the S&P Dow Jones Indices LLC proprietary allocation model. 詳細を表示

セクター
Mgmt Invt Offices, Open-end
業界
Mgmt Invt Offices, Open-end
ウェブサイト
本社
Wilmington, Delaware, USA
設立
-
iShares Core Moderate Allocation ETF is listed in the Mgmt Invt Offices, Open-end sector of the アメリカ証券取引所 with ticker AOM. The last closing price for Moderate Allocation ETF was US$44.05. Over the last year, Moderate Allocation ETF shares have traded in a share price range of US$ 39.9201 to US$ 45.31.

Moderate Allocation ETF currently has 31,800,000 shares in issue. The market capitalisation of Moderate Allocation ETF is US$1.40 billion. Moderate Allocation ETF has a price to earnings ratio (PE ratio) of 10.31.

AOM 最新ニュース

Business software firm ActiveOps raises GBP76 million in AIM float

ActiveOps PLC said Thursday it has raise GBP75.7 million gross for selling shareholders in its initial public offerin ...

Koronis Pharmaceuticals Appoints Stephen Becker, M.D., Chief Medical Officer

SEATTLE, Oct. 26 /PRNewswire/ -- Koronis Pharmaceuticals, Inc. today announced the appointment of Stephen Becker, M.D., as chief medical officer. Dr. Becker joins Koronis from AnorMED...

Poniard Pharmaceuticals Expands Picoplatin Agreement to Include Exclusive Worldwide Rights and Improved Financial Terms and Cond

Agreement Eliminates Development Milestones, Significantly Reduces Royalties and Restructures Sublicense Provisions SOUTH SAN FRANCISCO, Calif., Sept. 19 /PRNewswire-FirstCall/ -- Poniard...

AnorMED shares begin trading on NASDAQ

VANCOUVER, Sept. 7 /PRNewswire-FirstCall/ -- AnorMED Inc. (NASDAQ:ANOR; TSX:AOM) today announced that its common shares will begin trading on September 8, 2006 on the NASDAQ Global Market of the...

AnorMED Board recommends shareholders reject hostile Genzyme offer and not tender shares

VANCOUVER, Sept. 5 /PRNewswire-FirstCall/ -- AnorMED Inc. ("AnorMED" or the "Company") (AMEX:AOM; TSX:AOM) announced that its Board of Directors, based on the recommendation of its Strategic...

AnorMED advises shareholders to take no action on unsolicited takeover bid from Genzyme Corporation

VANCOUVER, Sept. 1 /PRNewswire-FirstCall/ -- AnorMED Inc. ("AnorMED" or the "Company") (AMEX:AOM; TSX:AOM) today confirmed that Genzyme Corp. has commenced an unsolicited offer through a...

Genzyme to Initiate Tender Offer to Acquire AnorMED, Inc.

Proposed Acquisition Will Add Complementary Late-Stage Transplant Product CAMBRIDGE, Mass., Aug. 30 /PRNewswire-FirstCall/ -- Genzyme Corporation (NASDAQ:GENZ) announced today that it plans to...

AnorMED rejects unsolicited approach from Genzyme

Considers Genzyme Proposal Undervalued VANCOUVER, Aug. 30 /PRNewswire-FirstCall/ -- AnorMED Inc. ("AnorMED" or the "Company") (AMEX:AOM; TSX:AOM) today announced that its Board of Directors has...

AnorMED announces NASDAQ listing and filing of shelf registration statement

VANCOUVER, Aug. 28 /PRNewswire-FirstCall/ -- AnorMED Inc. (AMEX:AOM;TSX:AOM) today announced that it has received approval from the NASDAQ Stock Market, Inc. to list its common shares on the...

AnorMED announces Annual and Special Meeting of Shareholders

VANCOUVER, Aug. 28 /PRNewswire-FirstCall/ -- AnorMED Inc. (AMEX:AOM;TSX:AOM) today announced that it has called the Company's 2006 Annual and Special Meeting of Shareholders to be held on...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.27-0.60920577617344.3244.332243.9113011444.07264265SP
4-0.15-0.33936651583744.244.6443.7611304144.18010922SP
12-0.24-0.54188304357644.2945.3143.769256744.41482513SP
261.353.1615925058542.745.3142.17069955143.72665741SP
524.0810.207655741839.9745.3139.920113852142.24926131SP
156-1.55-3.3991228070245.645.7335.7119307040.60256273SP
2604.3310.901309164139.7246.04533.2519082540.87796222SP

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
WORXSCWorx Corporation
US$ 1.93
(96.94%)
7.9M
PETWag Group Company
US$ 0.3126
(48.79%)
11.83M
AKTSAkoustis Technologies Inc
US$ 0.1294
(48.56%)
11.91M
ISTRInvestar Holding Corporation
US$ 29.99
(28.77%)
7
TCTMTCTM Kids IT Education Inc
US$ 1.09
(28.24%)
1
WSBFWaterstone Financial Inc
US$ 9.00
(-40.98%)
4
TRSTriMas Corporation
US$ 15.62
(-40.79%)
1
BCAXBicara Therapeutics Inc
US$ 11.00
(-40.15%)
101
PYXSPyxis Oncology Inc
US$ 2.35
(-38.48%)
109.93k
XNCRXencor Inc
US$ 15.11
(-36.30%)
2
AKTSAkoustis Technologies Inc
US$ 0.1294
(48.56%)
11.91M
PETWag Group Company
US$ 0.3126
(48.79%)
11.83M
XTKGX3 Holdings Company Ltd
US$ 0.0953
(5.89%)
8.63M
WORXSCWorx Corporation
US$ 1.93
(96.94%)
7.9M
CRKNCrown Electrokinetics Corporation
US$ 0.9741
(23.98%)
2.58M